Technology | June 22, 2015

ScanMed Introduces Non-Invasive Procure Prostate/Pelvic MRI Coil for Diagnosing Prostate Cancer

Device offers higher image quality, reducing high rates of false positives

ScanMed, ProCure, prostate/pelvic MRI coil, prostate cancer

June 22, 2015 - ScanMed announced the introduction of the non-invasive, wearable ProCure prostate/pelvic magnetic resonance imaging (MRI) coil to aid in diagnosing prostate cancer

According to the National Cancer Institute, prostate cancer is the most common cancer (1 of 6 men) inflicting men in the United States, after skin cancer. It is the second leading cause of death from cancer in men.

Men with elevated prostate-specific antigen (PSA) will often get a blind biopsy and are given a clean ill of health, even though such biopsies are reported to yield between 50 and 90 percent false negatives, meaning that the man did have cancer and it went undetected. After a cancer is left to grow for too long, then options are very few in terms of treatment - either complete removal of the prostate (prostatectomy) or thermal ablation of the entire organ.

The ProCure coil was born from evaluation of the current MRI tools available - non-dedicated antennae and endo-rectal coils that produced inadequate image quality or great reluctance or refusal of use, respectively. ProCure is a dedicated, diaper-like MRI coil which positions multiple antennae elements as close as possible to the target anatomies (the prostate and reproductive organs) regardless of patient size. The coil also allows for biopsy should a radiologist deem that a detected lesion warrants laboratory validation.

For more information: www.scanmed.com

Related Content

SpaceOAR Hydrogel Now Available in Japan
News | Patient Positioning Radiation Therapy | July 16, 2018
Augmenix K.K. announced that SpaceOAR hydrogel, a soft, implanted absorbable gel spacer is now available to all...
iSchemaView Brings RAPID Imaging Platform to Australia and New Zealand
News | Stroke | July 13, 2018
iSchemaView has signed Diagnostic Imaging Australia (DIA) to be the exclusive distributor for the RAPID cerebrovascular...
High-Strength MRI May Release Mercury from Amalgam Dental Fillings
News | Magnetic Resonance Imaging (MRI) | July 05, 2018
Exposure to ultra-high-strength magnetic resonance imaging (MRI) may release toxic mercury from amalgam fillings in...
Ensuring that the FMDS for MRI safety is mounted outside Zone IV provides maximum early warning.

Ensuring that the FMDS for MRI safety is mounted outside Zone IV provides maximum early warning. (Images courtesy of Metrasens)

Feature | Magnetic Resonance Imaging (MRI) | July 03, 2018 | By Tobias Gilk
Nearly every job in the country is subject to certain health and safety regulations. Construction workers must wear...
SNMMI Image of the Year Highlights Theranostic Approach for Advanced Prostate Cancer

IMAGE OF THE YEAR: PSMA PET before and after lutetium-177 PSMA617 theranostics in 8 patients with metastatic prostate cancer who exhausted standard therapeutic options.

68Ga-PSMA11 PET maximum intensity projection (MIP) images at baseline and 3 months after 177Lu-PSMA617 in 8 patients with PSA decline ≥ 98 percent in a prospective phase II study. Any disease with SUV over 3 is in red. Credit: Michael Hofman, John Violet, Shahneen Sandhu, Justin Ferdinandus, Amir Iravani, Grace Kong, Aravind Ravi Kumar, Tim Akhurst, Sue Ping Thang, Price Jackson, Mark Scalzo, Scott Williams and Rodney Hicks, Peter MacCallum Cancer Centre, Melbourne, Australia.

News | PET Imaging | June 29, 2018
In the battle against metastatic castrate-resistant prostate cancer, studies have demonstrated a high response rate to...
Technology | Magnetic Resonance Imaging (MRI) | June 27, 2018
June 27, 2018 — Zetta Medical Technologies announced the release of Zoom, its latest...
Children with Kidney Disease Show Blood Flow Changes in Brain
News | Neuro Imaging | June 25, 2018
Blood flow changes in the brains of children, adolescents and young adults with chronic kidney disease may explain why...
Technology | Focused Ultrasound Therapy | June 19, 2018
EDAP TMS SA has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Focal One device for...
New Prostate Cancer Radiotherapy Technique Aims to Preserve Sexual Function
News | Radiation Therapy | June 18, 2018
A multicenter clinical trial being led by UT Southwestern physicians is testing a technique for sparing nerve bundles...
Elekta Unity High-Field MR-Linac Receives CE Mark
News | Image Guided Radiation Therapy (IGRT) | June 18, 2018
Elekta announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received CE mark,...
Overlay Init